Metastatic Colorectal Cancer

Metastatic Colorectal Cancer - most related articles:

- FDA declines Fusilev NDA for colorectal cancer - 7.8
- Young women with colon cancer lived longer than men - 7.7
- Regorafenib improves survival of colorectal cancer patients - 7.6
- Surgery not necessary for most late stage colorectal cancers - 6.7
- Evaluating risk factors of sporadic colorectal cancer - 6.4
- Colonoscopy associated with reduced colorectal cancer incidence - 6.3
- Colorectal cancer deaths are down in US - 5.9
- New class of cancer drugs could work in colon cancers with genetic mutation - 5.6
- A genetic trait identified for colorectal cancer risk - 5.5
- Colorectal cancer screening guidelines update - 5.4

Metastatic Colorectal Cancer articles

Regorafenib improves survival of colorectal cancer patients
Regorafenib - an investigational drug - slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer. This is the first novel agent in eight years to show improvement in overall survival of colon cancer patients who have run out of treatment options.

FDA declines Fusilev NDA for colorectal cancer
A Complete Response letter is issued by the U.S. Food and Drug Administration (FDA) regarding the supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.

Young women with colon cancer lived longer than men
Younger women with metastatic colorectal cancer lived longer than younger men, revealed by researchers in a new US study. However, this survival advantage disappeared with age, suggesting a benefit from estrogen or other hormones.

Cetuximab for colorectal cancer with KRAS gene
From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a study published online August 7 in the Journal of the National Cancer Institute.

4 Metastatic Colorectal Cancer articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.75